# 2026-23206: CDC Seeks Public Input on a Future West Nile Vaccine

2026-23206, Target Product Profile for a Human West Nile Virus Vaccine: Request for Information, is a Federal Register notice from Health and Human Services Department, Centers for Disease Control and Prevention published 2026-11-16, effective 2027-01-15 (as of 2026-11-17).

- Canonical: https://policyrisk.com/federal-register/2026-23206
- As of: 2026-11-17
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2026-23206
- Title: Target Product Profile for a Human West Nile Virus Vaccine: Request for Information
- Type: Notice
- Agencies: Health and Human Services Department; Centers for Disease Control and Prevention
- Citation: 91 FR 73595
- Published: 2026-11-16
- Effective: 2027-01-15
- Comments close: 2027-01-15
- Significant: no
- Touches household money: no
- Regulation identifier numbers: none
- Last updated: 2026-11-17

## In one line

CDC Seeks Public Input on a Future West Nile Vaccine

## Summary

The CDC wants your thoughts on a plan for a new vaccine to protect people from West Nile Virus. This vaccine could help keep everyone safer, especially those at risk, and your feedback will shape its development. Make sure to share your ideas by January 15, 2027, so the CDC can create the best vaccine possible without delay or extra costs.

## Abstract

The Centers for Disease Control and Prevention (CDC) in the Department of Health and Human Services (HHS) announces the opening of a docket to obtain comment on the proposed Target Product Profile for a Human West Nile Virus Vaccine. This Request for Information (RFI) invites comments and suggestions on the proposed target product profile. The objective of the target product profile is to describe key minimal and optimal attributes for a West Nile virus vaccine for humans. This input is a valuable component in developing a useful target product profile.

## Effects PRIA read

No economic effects identified for this document.

## Related documents

- [2026-23004](https://policyrisk.com/federal-register/2026-23004): Final Effect of the Designation of a Class of Employees for Addition to the Special Exposure Cohort, 2026-11-12
- [2026-22881](https://policyrisk.com/federal-register/2026-22881): Proposed Data Collection Submitted for Public Comment and Recommendations, 2026-11-10
- [2026-22819](https://policyrisk.com/federal-register/2026-22819): Agency Forms Undergoing Paperwork Reduction Act Review, 2026-11-09
- [2026-22775](https://policyrisk.com/federal-register/2026-22775): Meeting of the Advisory Board on Radiation and Worker Health, National Institute for Occupational Safety and Health, 2026-11-09
- [2026-22330](https://policyrisk.com/federal-register/2026-22330): Agency Forms Undergoing Paperwork Reduction Act Review, 2026-11-02
- [2026-22329](https://policyrisk.com/federal-register/2026-22329): Agency Forms Undergoing Paperwork Reduction Act Review, 2026-11-02

## Sources
- [2026-23206 on federalregister.gov](https://www.federalregister.gov/documents/2026/11/16/2026-23206/target-product-profile-for-a-human-west-nile-virus-vaccine-request-for-information)
- [2026-23206 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2026-11-16/pdf/2026-23206.pdf)

## Related
- [Previous: 2026-23205, Target Product Profile for Monoclonal Antibodies for West Nile Virus Disease Pr…](https://policyrisk.com/federal-register/2026-23205)
- [Next: 2026-23207, Qualification of Drivers; Exemption Applications; Implantable Cardioverter Defi…](https://policyrisk.com/federal-register/2026-23207)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2026-23206 (as of 2026-11-17).
